RSAD2 and COVID-19: A significant decrease was observed for FI44L, MX1, RSAD2, ISIG15, and IFIT1 (Fig 6B–6G) indicating a dysregulated type I/III interferon response in COVID-19 patients with pneumonia with a downregulation of ISGs.